Answers are grounded in this paper and cite their sources.
Background Guided Bone Regeneration (GBR) using resorbable barrier membranes is a predictable technique for localized alveolar ridge augmentation. This study evaluated 5-year radiographic marginal bone loss (MBL) around implants placed in sites augmented with native collagen versus pericardium membranes. Methods In a retrospective cohort design, a total of 53 patients receiving 120 implants with Class II or III alveolar bone defects were included. Patients received horizontal ridge augmentation using either native collagen (n = 29 patients, 65 implants) or pericardium (n = 24 patients, 55 implants) membranes paired with a 1:1 mixture of autogenous bone and xenograft. The primary statistical unit of analysis was the patient (n = 53). Radiographic MBL was evaluated on standardized periapical radiographs taken at implant crown connection/loading (T0), 1 year (T1), and 5 years (T5) post-loading.Patient-level mean MBL was analyzed, and inter-group comparisons at 5 years were performed using Welch's t-test (alpha = 0.05). Results At 5 years post-loading, the mean MBL was 1.285 ± 0.946 mm for the collagen membrane group and 1.324 ± 1.046 mm for the pericardium membrane group. The observed inter-group difference was minimal (-0.0395 mm; 95% CI: -0.596 to 0.517 mm; Cohen's d = -0.040), with no statistically significant difference detected between the two barrier materials (p = 0.8869). Longitudinal changes from T0 to T5 showed stable crestal bone levels in both cohorts. Overall implant survival was 100%. Conclusions Within the limitations of this retrospective observational study, no statistically significant differences in 5-year radiographic marginal bone loss were detected between native collagen and pericardium barrier membranes. Given the wide confidence interval and limited statistical power, non-inferiority or equivalence cannot be formally concluded, and these findings should be considered hypothesis-generating. Clinical Relevance: Clinicians may consider both native collagen and pericardium membranes as suitable options for GBR in Class II and III defects, selecting the appropriate barrier based on handling characteristics, defect morphology, tensile requirements, and cost efficiency, without observing significant differences in long-term interproximal bone level stability. Clinical trial registration Not applicable. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Gandolfi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: